300750 CONTEMPORARY AMPEREX TECHNOLOGY CO

Dr. Wolff Group: Dr. Wolff’s Vagisan introduces hormone-free Moisturising Cream and Moisturising Cremolum, clinically proven to soothe vaginal dryness

Dr. Wolff Group
Dr. Wolff Group: Dr. Wolff’s Vagisan introduces hormone-free Moisturising Cream and Moisturising Cremolum, clinically proven to soothe vaginal dryness

18-Oct-2023 / 11:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


Dr. Wolff’s Vagisan introduces hormone-free Moisturising Cream and Moisturising Cremolum, clinically proven to soothe vaginal dryness

 

HONG KONG SAR -  - 18 October 2023 - Many woman experiencing menopause are troubled by vaginal dryness. It can cause discomfort when sitting, standing, exercising, during urinating and even working, and can greatly impact their quality of life. In Hong Kong, every 2 out of 3 women has experienced symptoms of Vaginal Dryness1. Yet, it remains a taboo topic, making it difficult for women to discuss their intimate health concerns with family, friends, or doctors, resulting in only one-quarter of affected woman seeking treatment2.

Vaginal secretions gradually decrease as a woman ages, resulting in decreased lubrication and elasticity of the vaginal tissue. This can result in vaginal dryness and associated symptoms such as dryness, itching, burning, and pain3. Given that these symptoms closely resemble those associated with other vaginal flora issues, many women have been perplexed and resorted to over-the-counter remedies, which may exacerbate the situation2.

Symptoms of vaginal dryness can also be mistaken for poor hygiene. In fact, excessive cleansing of the intimate area with conventional soaps and vaginal douching, may risk irritating the vaginal skin and disrupt the vaginal flora, leading to worsening of the condition.

Soothing Vaginal Dryness with the right products
fncls.ssp?fn=download2_file&code_str=3122b471ed5f79a447862054ae51492b


 

Dr Dawn Harper, a general practitioner in United Kingdom known for her expertise on menopause, emphasises on the importance for women suffering from vaginal dryness to use a moisturising cream with high water content and lipids which can provide lasting soothing relief for women experiencing Vaginal Dryness.

Introducing Hormone-Free Dr. Wolff’s Vagisan Moisturising Cream and Moisturising Cremolum
fncls.ssp?fn=download2_file&code_str=1012ac60e80429e10d1606539ba27c16

 

Dr. Wolff’s Vagisan Moisturising Cream
 

  • Effectively relieves dryness, itching, burning and pain associated with vaginal dryness
  • Contains high water content and soothing lipids, keeps skin of intimate area soft and supple
  • Contains lactic acid and is thus adjusted to the healthy pH level in the vagina
  • Hormone-free and can be applied intravaginally and to the external genital area


Clinically proven to relieve symptoms of vaginal dryness

Dr. Wolff’s Vagisan Moisturising Cream can not only moisturises the internal and external skin of the vagina, but also supplies it with nourishing lipids, leaving the skin of the intimate area supple and soft.

Several clinical studies have been performed with Dr. Wolff’s Vagisan Moisturising Cream, proving its efficacy and tolerability. Not only did the cream show superior efficacy as well as tolerability as compared to a water-based non-hormonal gel4, but it was statistically significantly non-inferior to a hormone-containing cream (estriol 0.1%) in terms of improvement on subjective symptoms of vaginal dryness5.

Also available as an innovative pessary for greater convenience without the use of an applicator: Dr. Wolff’s Vagisan Moisturising Cremolum
 

  • Smooth melting pessary, forms into a cream in the vagina together with vaginal fluids
  • Individually wrapped for more hygiene and convenience
  • Hormone-free and can be applied intravaginally
  • Free from preservatives


A Dr.Wolff’s clinical study6 also found that the Dr. Wolff’s Vagisan Moisturising Cremolum provided a long-lasting soothing effect that lasted 3 days or longer for majority of participants. It significantly improves the symptoms of dryness, itching, burning, and pain associated with vaginal dryness and provides relief from first application, allowing these women to achieve a better quality of life. Furthermore, 90% of test participants rated the moisturising cremolum as very easy or simple to use.

For more questions on the products mentioned above, please refer to Dr. Wolff’s Vagisan official site: 

1 Survey Aug 2016, Vaginal Dryness, n=400 Hong Kong women (aged 41-55), conducted by AIP Global, Singapore

2 Womens’s Health Concern (2022,) 

3 Family Health Service (2022, February) 

4 Stute, P., May, T. W., Masur, C., & Schmidts-Winkler, I. M. (2015). Efficacy and safety of non-hormonal remedies for vaginal dryness: open, prospective, randomized trial. Climacteric : the journal of the International Menopause Society, 18(4), 582–589. 

5Garcia de Arriba, S., Grüntkemeier, L., Häuser, M., May, T. W., Masur, C., & Stute, P. (2022). Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study. PloS one, 17(5), e0266633. 

6Clinical trial over 6 weeks with n=79 postmenopausal women with vaginal dryness ()

 

About Dr. Wolff

Founded in 1905, Dr. Wolff is one of the largest medium-sized family-owned businesses in the Germany.

The Dr. Wolff Group consists of the owner-managed companies Dr. Kurt Wolff, Dr. August Wolff and their international subsidiaries. Distinguished by the development and creative marketing of real innovations for more than 100 years, the company concentrates on products which embody verifiable advantages for consumers.

For more information, please visit: Dr. Wolff Group ()

 



Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1751793  18-Oct-2023 

fncls.ssp?fn=show_t_gif&application_id=1751793&application_name=news&site_id=research_pool
EN
18/10/2023

Underlying

300750CONTEMPORARY AMPEREX TECHNOLOGY CO

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CONTEMPORARY AMPEREX TECHNOLOGY CO

 PRESS RELEASE

EQS-News: vbw Pressemitteilung zum Koalitionsvertrag: Gute Grundlage

Emittent / Herausgeber: ibw – Informationszentrale der Bayerischen Wirtschaft e. V. / Schlagwort(e): Sonstiges/Sonstiges vbw Pressemitteilung zum Koalitionsvertrag: Gute Grundlage 10.04.2025 / 09:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. vbw zum Koalitionsvertrag: Gute Grundlage Brossardt: „Koalitionsvertrag schafft Planungssicherheit und setzt Wachstumsimpulse“  Bertram Brossardt, Hauptgeschäftsführer der vbw – Vereinigung der Bayerischen Wirtschaft e. V.: (München, 09.04.2025). Wir freuen uns, dass jetzt der Weg frei ist f...

 PRESS RELEASE

Aquis Stock Exchange - suspension of trading

Aquis Stock Exchange Aquis Stock Exchange - suspension of trading 10-Apr-2025 / 07:00 GMT/BST The issuer is solely responsible for the content of this announcement. The following securities are suspended from trading on the Aquis Growth Market from 08.00, 10 April 2025, at the request of the company: Richmond Hill Resources Plc Ordinary Shares Symbol: SHNJ ISIN: GB00BNTBWF32 The Regulation Department Aquis Stock Exchange Floor 2, 63 Queen Victoria Street, EC4N 4UA Tel: 0203 597 6361 Email:  Website:  Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The i...

 PRESS RELEASE

EQS-News: CO2Coin one of the most successful crypto investments of the...

Issuer: Clima4Future Ltd. / Key word(s): Cryptocurrency / Blockchain/Market Launch CO2Coin one of the most successful crypto investments of the coming decades. 10.04.2025 / 04:55 CET/CEST The issuer is solely responsible for the content of this announcement.     CO2Coin is going through a phase of phenomenal growth. A year ago the price was just €1, today it is around 270 USDT - an increase in value that illustrates the enormous potential of this unique project. This development reflects the crypto community's growing interest in sustainable investments. Clima4Future Lt...

 PRESS RELEASE

EQS-News: CO2Coin eine der erfolgreichsten Krypto-Investitionen der ko...

Emittent / Herausgeber: Clima4Future Ltd. / Schlagwort(e): Kryptowährung / Blockchain/Markteinführung CO2Coin eine der erfolgreichsten Krypto-Investitionen der kommenden Jahrzehnte. 10.04.2025 / 04:55 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Der CO2Coin hat einen beeindruckenden Kursanstieg erlebt. Vor einem Jahr lag der Kurs noch bei 1 €, heute liegt er bei rund 270 USDT - eine Wertsteigerung, die das enorme Potenzial dieses einzigartigen Projekts verdeutlicht. Diese Entwicklung spiegelt das wachsende Interesse der Krypto-Com...

 PRESS RELEASE

EQS-News: Zimbabwe Government Delivers on Commitment: Compensation of ...

EQS-News: Zimbabwe Ministry of Finance, Economic Development and Investment Promotion / Key word(s): Miscellaneous Zimbabwe Government Delivers on Commitment: Compensation of Former Farm Owners under the Global Compensation Deed Commences 09.04.2025 / 20:20 CET/CEST The issuer is solely responsible for the content of this announcement. In line with the GCD agreement, the FFOs receive 1 per cent of their claim in cash, with the balance being paid through US$ denominated Treasury bonds with a 2 per cent coupon and maturities of 2 to 10 years HARARE, Zimbabwe, April 9, 2025...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch